Lesson plan

Biscaline

Biscaline, also known as 3,5-dimethoxy-4-phenylphenethylamine, is a monoamine receptor modulator of the phenethylamine and desoxyscaline families. It is the analogue of mescaline (3,4,5-dimethoxyphenethylamine) in which the methoxy group at the 4 position has been replaced with a phenyl ring. The drug shows affinity for the serotonin 5-HT 1A receptor (K i = 4,021 nM). Conversely, it did not bind to the serotonin 5-HT 2A , 5-HT 2B , or 5-HT 2C receptors at the assessed concentrations (K i = >13,400 nM, >10,000 nM, and >14,590 nM, respectively). It is said to have lacked activational effects on the serotonin 5-HT 2A and 5-HT 2B receptors at the assessed concentrations. Biscaline also bound to the α 2A -adrenergic receptor (K i = 797 nM), but not to the α 1A -adrenergic receptor, the dopamine D 2 receptor, or the monoamine transporters ( , , or ) at the assessed concentrations (K i = >7,510–10,550 nM). It was a very weak monoamine reuptake inhibitor, with values of 457,000 nM for serotonin, 160,000 nM for norepinephrine, and 573,000 nM for dopamine. Besides the monoamine receptors and transporters, biscaline showed affinity for the rat trace amine-associated receptor 1 (TAAR1) (K i = 586 nM), but not for the mouse TAAR1 (K i = >4,270 nM) and did not activate the human TAAR1 ( = >30,000 nM).…

Back to article

Article summary

Biscaline, also known as 3,5-dimethoxy-4-phenylphenethylamine, is a monoamine receptor modulator of the phenethylamine and desoxyscaline families. It is the analogue of mescaline (3,4,5-dimethoxyphenethylamine) in which the methoxy group at the 4 position has been replaced with a phenyl ring. The drug shows affinity for the serotonin 5-HT 1A receptor (K i = 4,021 nM). Conversely, it did not bind to the serotonin 5-HT 2A , 5-HT 2B , or 5-HT 2C receptors at the assessed concentrations (K i = >13,400 nM, >10,000 nM, and >14,590 nM, respectively). It is said to have lacked activational effects on the serotonin 5-HT 2A and 5-HT 2B receptors at the assessed concentrations. Biscaline also bound to the α 2A -adrenergic receptor (K i = 797 nM), but not to the α 1A -adrenergic receptor, the dopamine D 2 receptor, or the monoamine transporters ( , , or ) at the assessed concentrations (K i = >7,510–10,550 nM). It was a very weak monoamine reuptake inhibitor, with values of 457,000 nM for serotonin, 160,000 nM for norepinephrine, and 573,000 nM for dopamine. Besides the monoamine receptors and transporters, biscaline showed affinity for the rat trace amine-associated receptor 1 (TAAR1) (K i = 586 nM), but not for the mouse TAAR1 (K i = >4,270 nM) and did not activate the human TAAR1 ( = >30,000 nM).…

Key claims

No claims recorded.

Discussion questions

  1. Summarise the article in your own words. Which single claim would you verify first, and why?
  2. Which claim in this article is most likely to be revised as the sources update? How would you check its current status?
  3. If two sources disagreed about one of these facts, what would you need in order to trust one over the other?

Bibliography

No sources recorded.

Key claims and bibliography are generated from the same tracked claims and sources as the article page.